Evaluating Control of Hypertension - Effect of Social Determinants
ECHOES
1 other identifier
observational
1,939,783
1 country
1
Brief Summary
This study evaluates the impact of a large-scale, national expansion of Medicaid on hypertension incidence, screening, treatment, and management. Social Determinants of Health will be assessed as moderators, and comparing states that did versus states that did not expand Medicaid will also be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 22, 2018
CompletedFirst Posted
Study publicly available on registry
June 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2023
CompletedApril 18, 2024
April 1, 2024
5 years
May 22, 2018
April 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Hypertension incidence
Rates of hypertension diagnosis using the following codes in the EHR: ICD-9: 401.00-401.99, 402.00-405.99 or ICD-10: I10-I15.
24 months prior to Medicaid expansion vs 24 months post
Undiagnosed hypertension
high blood pressure but no diagnosis or medications can be noted in the EHR diagnostic codes that can be used to document why a diagnosis of hypertension was not made including ICD-10 R03.0 (i.e., white coat syndrome without HTN) and ICD-9 796.2 (i.e., elevated BP without HTN).
24 months prior to Medicaid expansion vs 24 months post
Hypertension screening
rate of blood pressure screening marked in EHR
24 months prior to Medicaid expansion vs 24 months post
Hypertension treatment
the number of anti-hypertensive medications prescribed in EHR
24 months prior to Medicaid expansion vs 24 months post
Hypertension management
blood pressure control: last measure within range of normal for age/risk(s); percent Y/N at last visit, value/date of last measure
24 months prior to Medicaid expansion vs 24 months post
Secondary Outcomes (4)
Insurance status and rates of coverage
24 months prior to Medicaid expansion vs 24 months post
Service Utilization
24 months prior to Medicaid expansion vs 24 months post
Preventive service receipt
24 months prior to Medicaid expansion vs 24 months post
Hypertension related complications
24 months prior to Medicaid expansion vs 24 months post
Study Arms (2)
Medicaid Expansion States
Patients receiving care in community health centers in states that expanded Medicaid (intervention group)
Non Medicaid Expansion States
Patients receiving care in community health centers in states that did not expand Medicaid (control group)
Interventions
There will be no direct intervention, but rather an observation of change based on whether a state expanded Medicaid or not
Eligibility Criteria
Study eligible patients within electronic health record data from the Accelerating Data Value Across a National Community Health Center Network (ADVANCE) community health information network
You may qualify if:
- Patients in intervention and control states aged 19-64
You may not qualify if:
- Patients outside of age range 19-64
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oregon Health and Science Universitylead
- OCHIN, Inc.collaborator
- National Institutes of Health (NIH)collaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
- Health Choice Networkcollaborator
- Fenway Community Healthcollaborator
Study Sites (1)
Oregon Health & Science University
Portland, Oregon, 97239, United States
Related Publications (2)
Huguet N, Larson A, Angier H, Marino M, Green BB, Moreno L, DeVoe JE. Rates of Undiagnosed Hypertension and Diagnosed Hypertension Without Anti-hypertensive Medication Following the Affordable Care Act. Am J Hypertens. 2021 Sep 22;34(9):989-998. doi: 10.1093/ajh/hpab069.
PMID: 33929496DERIVEDAngier H, Huguet N, Marino M, Green B, Holderness H, Gold R, Hoopes M, DeVoe J. Observational study protocol for evaluating control of hypertension and the effects of social determinants. BMJ Open. 2019 Mar 15;9(3):e025975. doi: 10.1136/bmjopen-2018-025975.
PMID: 30878987DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair of the Department of Family Medicine
Study Record Dates
First Submitted
May 22, 2018
First Posted
June 4, 2018
Study Start
April 1, 2018
Primary Completion
April 1, 2023
Study Completion
May 15, 2023
Last Updated
April 18, 2024
Record last verified: 2024-04